Biomarkers, menopausal hormone therapy and risk of venous thrombosis: The Women's Health Initiative-Reference-Cited by-同舟云学术

Biomarkers, menopausal hormone therapy and risk of venous thrombosis: The Women's Health Initiative

Published:2018-04 Issue:2 Volume:2 Page:310-319
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Cushman Mary¹^ORCID,Larson Joseph C.²,Rosendaal Frits R.³^ORCID,Heckbert Susan R.⁴,Curb J. David⁵,Phillips Lawrence S.⁶⁷,Baird Alison E.⁸,Eaton Charles B.⁹¹⁰,Stafford Randall S.¹¹

Affiliation:

1. Department of Medicine; Larner College of Medicine; University of Vermont; Burlington VT USA

2. Public Health Sciences Division; Fred Hutchinson Cancer Research Center; Seattle WA USA

3. Department of Clinical Epidemiology; Leiden University Medical Center; Leiden the Netherlands

4. Department of Epidemiology; Cardiovascular Health Research Unit; University of Washington; Seattle WA USA

5. Department of Geriatric Medicine; University of Hawaii; Honolulu HI USA

6. Atlanta VA Medical Center; Decatur GA USA

7. Division of Endocrinology and Metabolism; Emory University School of Medicine; Atlanta GA USA

8. Department of Neurology; State University of New York Downstate Medical Center; Brooklyn NY USA

9. Department of Family Medicine; Alpert Medical School; Brown University; Providence RI USA

10. Department of Epidemiology; School of Public Health; Brown University; Providence RI USA

11. Program on Prevention Outcomes and Practices; Stanford Prevention Research Center; Stanford University; Palo Alto CA USA

Funder

National Heart, Lung, and Blood Institute

U.S. Department of Health and Human Services

Publisher

Wiley

Subject

Hematology

Reference35 articles.

1. Estrogen plus progestin and risk of venous thrombosis;Cushman;JAMA,2004

2. Venous thrombosis and conjugated equine estrogen in women without a uterus;Curb;Arch Intern Med,2006

3. Epidemiology and risk factors for venous thrombosis;Cushman;Semin Hematol,2007

4. Effects of hormone replacement therapy on coagulation, fibrinolysis, and thrombosis risk in postmenopausal women;Koh;Thromb Haemost,1999

5. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) study;Cushman;Circulation,1999

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays;Research and Practice in Thrombosis and Haemostasis;2023-08

2. Menopause Is a Natural Condition: Does It Require to Be Corrected? For Whom and for How Long?;Amenorrhea;2023

3. A Green Blue LED-Driven Two-Liquid-Phase One-Pot Procedure for the Synthesis of Estrogen-Related Quinol Prodrugs;Molecules;2022-12-16

4. Estetrol is not a SERM but a NEST and has a specific safety profile on coagulation;Thrombosis Research;2022-09

5. Dietary genistein and 17β-estradiol implants differentially influence locomotor and cognitive functions following transient focal ischemia in middle-aged ovariectomized rats at different lengths of estrogen deprivation;Hormones and Behavior;2022-08